Immunosuppressive CD14+ HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation

Leukemia

Volumn 27, Issue 2, 2013, Pages 377-388

  Mougiakakos, D ^a,b   Jitschin, R ^a   Von Bahr, L ^a   Poschke, I ^c   Gary, R ^b   Sundberg, B ^a   Gerbitz, A ^b   Ljungman, P ^a   Le Blanc, K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD14 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 6;

ADULT; ARTICLE; CELL DEATH; CELL ISOLATION; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD14; BLOTTING, WESTERN; CELL PROLIFERATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MALE; MIDDLE AGED; MONOCYTES; MYELOID CELLS; OXIDATIVE STRESS; PHOSPHORYLATION; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 84873569840     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.215     Document Type: Article

References (52)

1. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-174.
2. Cheron A, Floccard B, Allaouchiche B, Guignant C, Poitevin F, Malcus C et al. Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care 2010; 14: R208.
3. Poschke I, Mougiakakos D, Hansson J, Masucci GV, Kiessling R. Immature immunosuppressive CD14\+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res 2010; 70: 4335-4345.
4. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009; 182: 4499-4506.
5. Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, Dolcetti L et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010; 32: 790-802.
6. Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 2010; 185: 2273-2284.
7. Lechner MG, Megiel C, Russell SM, Bingham B, Arger N, Woo T et al. Functional characterization of human Cd33\+ and Cd11b\+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines. J Transl Med 2011; 9: 90.
8. Filipazzi P, Huber V, Rivoltini L. Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol Immunother 2012; 61: 255-263.
9. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S et al. Myeloidderived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 2010; 22: 238-244.
10. Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Kubler H et al. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin Cancer Res 2008; 14: 8270-8278.
11. Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol 2009; 182: 5693-5701.
12. Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Kruger C, Manns MP et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(\+)CD25(\+)Foxp3(\+) T cells. Gastroenterology 2008; 135: 234-243.
13. Loercher AE, Nash MA, Kavanagh JJ, Platsoucas CD, Freedman RS. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J Immunol 1999; 163: 6251-6260.
14. MacDonald KP, Rowe V, Clouston AD, Welply JK, Kuns RD, Ferrara JL et al. Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells. J Immunol 2005; 174: 1841-1850.
15. Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S. Myeloidderived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 70: 68-77.
16. Vuk-Pavlovic S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X et al. Immunosuppressive CD14\+HLA-DRlow/-monocytes in prostate cancer. Prostate 2010; 70: 443-455.
17. Lin Y, Gustafson MP, Bulur PA, Gastineau DA, Witzig TE, Dietz AB. Immunosuppressive CD14\+HLA-DR(low)/-monocytes in B-cell non-Hodgkin lymphoma. Blood 2011; 117: 872-881.
18. Hoechst B, Gamrekelashvili J, Manns MP, Greten TF, Korangy F. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 2011; 117: 6532-6541.
19. Luyckx A, Schouppe E, Rutgeerts O, Lenaerts C, Koks C, Fevery S et al. Subset characterization of myeloid-derived suppressor cells arising during induction of BM chimerism in mice. Bone Marrow Transplant 2012; 47: 985-992.
20. Ghansah T, Paraiso KH, Highfill S, Desponts C, May S, McIntosh JK et al. Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses. J Immunol 2004; 173: 7324-7330.
21. Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, Veenstra R et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 2010; 116: 5738-5747.
22. Seggewiss R, Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 2010; 115: 3861-3868.
23. Solito S, Falisi E, Diaz-Montero CM, Doni A, Pinton L, Rosato A et al. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 118: 2254-2265.
24. Landfried K, Zhu W, Waldhier MC, Schulz U, Ammer J, Holler B et al. Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenase. Blood 2011; 118: 6971-6974.
25. Hainz U, Obexer P, Winkler C, Sedlmayr P, Takikawa O, Greinix H et al. Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation. Blood 2005; 105: 4127-4134.
26. Mattsson J, Uzunel M, Tammik L, Aschan J, Ringden O. Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation. Leukemia 2001; 15: 1976-1985.
27. Yang R, Cai Z, Zhang Y, WHT Yutzy, Roby KF, Roden RB. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1\+CD11b\+ myeloid cells. Cancer Res 2006; 66: 6807-6815.
28. Pan PY, Ma G, Weber KJ, Ozao-Choy J, Wang G, Yin B et al. Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res 2010; 70: 99-108.
29. Lob S, Konigsrainer A, Rammensee HG, Opelz G, Terness P. Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer 2009; 9: 445-452.
30. Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69: 1553-1560.
31. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008; 181: 5791-5802.
32. De Wilde V, Van Rompaey N, Hill M, Lebrun JF, Lemaitre P, Lhomme F et al. Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant 2009; 9: 2034-2047.
33. Mougiakakos D, Jitschin R, Johansson CC, Okita R, Kiessling R, Le Blanc K. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 2011; 117: 4826-4835.
34. Kusmartsev S, Gabrilovich DI. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J Immunol 2005; 174: 4880-4891.
35. Bronte V, Serafini P, De Santo C, Marigo I, Tosello V, Mazzoni A et al. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J Immunol 2003; 170: 270-278.
36. Chakraverty R, Cote D, Buchli J, Cotter P, Hsu R, Zhao G et al. An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J Exp Med 2006; 203: 2021-2031.
37. Bharadwaj U, Li M, Zhang R, Chen C, Yao Q. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res 2007; 67: 5479-5488.
38. Mougiakakos D, Choudhury A, Lladser A, Kiessling R, Johansson CC. Regulatory T cells in cancer. Adv Cancer Res 2010; 107: 57-117.
39. Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 2007; 179: 977-983.
40. Thibodeau J, Bourgeois-Daigneault MC, Huppe G, Tremblay J, Aumont A, Houde M et al. Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur J Immunol 2008; 38: 1225-1230.
41. Cuenca AG, Delano MJ, Kelly-Scumpia KM, Moreno C, Scumpia PO, Laface DM et al. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med 2011; 17: 281-292.
42. Mielcarek M, Martin PJ, Torok-Storb B. Suppression of alloantigen-induced T-cell proliferation by CD14\+ cells derived from granulocyte colony-stimulating factormobilized peripheral blood mononuclear cells. Blood 1997; 89: 1629-1634.
43. Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008; 205: 2235-2249.
44. Obermajer N, Muthuswamy R, Lesnock J, Edwards RP, Kalinski P. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood 2011; 118: 5498-5505.
45. Banovic T, Markey KA, Kuns RD, Olver SD, Raffelt NC, Don AL et al. Graft-versushost disease prevents the maturation of plasmacytoid dendritic cells. J Immunol 2009; 182: 912-920.
46. Von Bubnoff D, Scheler M, Wilms H, Fimmers R, Bieber T. Identification of IDOpositive and IDO-negative human dendritic cells after activation by various proinflammatory stimuli. J Immunol 2011; 186: 6701-6709.
47. Joo YD, Lee SM, Lee SW, Lee WS, Park JK, Choi IW et al. Granulocyte colonystimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase- independent mechanism. Immunology 2009; 128(Suppl): e632-e640.
48. Lin MT, Tseng LH, Frangoul H, Gooley T, Pei J, Barsoukov A et al. Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Blood 2000; 95: 3832-3839.
49. Nausch N, Galani IE, Schlecker E, Cerwenka A. Mononuclear myeloid-derived 'suppressor' cells express RAE-1 and activate natural killer cells. Blood 2008; 112: 4080-4089.
50. Apolloni E, Bronte V, Mazzoni A, Serafini P, Cabrelle A, Segal DM et al. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J Immunol 2000; 165: 6723-6730.
51. Meisel R, Brockers S, Heseler K, Degistirici O, Bulle H, Woite C et al. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia 2011; 25: 648-654.
52. Varga G, Ehrchen J, Tsianakas A, Tenbrock K, Rattenholl A, Seeliger S et al. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells. J Leukoc Biol 2008; 84: 644-650.